Lilly reports four-year remission data for ulcerative colitis drug
Go back to Lilly reports four-year remission data for ulcerative colitis drug| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1218.81 +35.65 (3.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1183.16 | 52 Week High | $88.16 | |||
| Open | $1200.00 | 52 Week Low | $67.88 | |||
| Day High | $1225.50 | P/E | 282.13 | |||
| Day Low | $1194.01 | EPS | $4.32 | |||
| Volume | 957,323 | |||||
